Mainz, Germany; Munich, Germany | full time | Job ID: 11699
About the role:
Are you passionate about advancing innovative therapies from discovery into the clinic? As Associate Director Bioanalytics, you will play a pivotal role in shaping biomarker and bioanalytical strategies across multiple clinical development programs, with a particular focus on biologics and antibody-drug conjugates (ADCs).
In this role, you will work at the interface of science, clinical development, and external partnerships to drive the selection, development, transfer, and validation of cutting-edge bioanalytical methods. Your contributions will support critical decision-making in drug development and diagnostics while ensuring alignment with BioNTech’s mission.
Your Contribution:
A Good Match:
Your Benefits:
It's our priority to support you:
Apply now - We look forward to your application!
Apply to our Mainz, Germany; Munich, Germanylocation by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 11699 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘HireRight’. You will be informed accordingly by your BioNTech-Recruiter.

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases.
BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress.
BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years.
Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html
🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html
🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html